Simple Summary Cholangiocarcinoma (CCA) is a heterogenous and aggressive
malignancy of the intra-and extrahepatic biliary tract, marked by a steeply rising incidence …

Carbohydrate antigen 19.9 (CA19. 9) is used as a tumor marker for clinical and research
purposes assuming that it is abundantly produced by gastrointestinal cancer cells due to a …

Prognostic features in advanced perihilar cholangiocarcinoma (pCCA) patients who
received first-line hepatic arterial infusion chemotherapy (HAIC) are unknown. The purpose …

Background. In recent years, there is growing literature on the prognostic significance of
programmed death‐ligand 1 (PD‐L1) in cholangiocarcinoma (CCA); however, data have …

Human Vγ9Vδ2 T lymphocytes are regarded as promising effector cells for cancer
immunotherapy since they have the ability to eliminate several tumor cells through non …

Abstract Common Non communicable diseases (NCDs), such as cardiovascular disease,
cancer, schizophrenia, and diabetes, have become the major cause of death in the world …

Introduction The development of novel biomarkers for cancer has exploded over the last
decade with advances in novel technologies. Cholangiocarcinoma (CCA), a cancer of the …

Cholangiocarcinoma (CCA) is an aggressive tumor of the bile duct with a high rate of
mortality. Lymph node metastasis is an important factor facilitating the progression of CCA. A …

Objectives Cholangiocarcinoma (CCA) is a rare tumor with a poor prognosis and poses
significant therapeutic challenges. Herein, we investigated the mechanism of efficacy of 125I …

Objective Hepatocellular carcinoma (HCC) and cholangiocellular carcinoma (CCA)
represent the most common malignant tumors of the liver. MicroRNAs (miRNAs) are small …